198 related articles for article (PubMed ID: 37491794)
21. Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.
Zhao Y; Tindall DJ; Huang H
Int J Biol Sci; 2014; 10(6):614-9. PubMed ID: 24948874
[TBL] [Abstract][Full Text] [Related]
22. FOXA1 in prostate cancer.
Dong HY; Ding L; Zhou TR; Yan T; Li J; Liang C
Asian J Androl; 2023; 25(3):287-295. PubMed ID: 36018068
[TBL] [Abstract][Full Text] [Related]
23. FOXA1: a transcription factor with parallel functions in development and cancer.
Bernardo GM; Keri RA
Biosci Rep; 2012 Apr; 32(2):113-30. PubMed ID: 22115363
[TBL] [Abstract][Full Text] [Related]
24. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.
Imamura Y; Sakamoto S; Endo T; Utsumi T; Fuse M; Suyama T; Kawamura K; Imamoto T; Yano K; Uzawa K; Nihei N; Suzuki H; Mizokami A; Ueda T; Seki N; Tanzawa H; Ichikawa T
PLoS One; 2012; 7(8):e42456. PubMed ID: 22879989
[TBL] [Abstract][Full Text] [Related]
25. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.
Gao N; Ishii K; Mirosevich J; Kuwajima S; Oppenheimer SR; Roberts RL; Jiang M; Yu X; Shappell SB; Caprioli RM; Stoffel M; Hayward SW; Matusik RJ
Development; 2005 Aug; 132(15):3431-43. PubMed ID: 15987773
[TBL] [Abstract][Full Text] [Related]
26. FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
He Y; Wang L; Wei T; Xiao YT; Sheng H; Su H; Hollern DP; Zhang X; Ma J; Wen S; Xie H; Yan Y; Pan Y; Hou X; Tang X; Suman VJ; Carter JM; Weinshilboum R; Wang L; Kalari KR; Weroha SJ; Bryce AH; Boughey JC; Dong H; Perou CM; Ye D; Goetz MP; Ren S; Huang H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34101624
[TBL] [Abstract][Full Text] [Related]
27. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.
Tsourlakis MC; Eleftheriadou A; Stender A; Weigand P; Grupp K; Hube-Magg C; Kluth M; Schroeder C; Steurer S; Hinsch A; Luebke A; Angerer A; Wittmer C; Friedrich E; Göbel C; Büscheck F; Heinzer H; Graefen M; Simon R; Sauter G; Wilczak W; Minner S; Schlomm T; Jacobsen F
Carcinogenesis; 2017 Dec; 38(12):1180-1187. PubMed ID: 29029032
[TBL] [Abstract][Full Text] [Related]
28. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
29. The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization.
Tang DE; Dai Y; Xu Y; Lin LW; Liu DZ; Hong XP; Ou ML; Jiang HW; Xu SH
Carcinogenesis; 2020 Mar; 41(1):56-66. PubMed ID: 31046116
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of FOXA1 inhibits cell proliferation and EMT of human gastric cancer AGS cells.
Lin M; Pan J; Chen Q; Xu Z; Lin X; Shi C
Gene; 2018 Feb; 642():145-151. PubMed ID: 29129808
[TBL] [Abstract][Full Text] [Related]
31. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
32. Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer.
Park SH; Fong KW; Kim J; Wang F; Lu X; Lee Y; Brea LT; Wadosky K; Guo C; Abdulkadir SA; Crispino JD; Fang D; Ntziachristos P; Liu X; Li X; Wan Y; Goodrich DW; Zhao JC; Yu J
Sci Adv; 2021 Apr; 7(15):. PubMed ID: 33827814
[TBL] [Abstract][Full Text] [Related]
33. FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Albayrak G; Konac E; Ugras Dikmen A; Bilen CY
Exp Biol Med (Maywood); 2018 Aug; 243(12):990-994. PubMed ID: 30043639
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity.
Potter AS; Casa AJ; Lee AV
J Cell Biochem; 2012 Jan; 113(1):110-21. PubMed ID: 21882221
[TBL] [Abstract][Full Text] [Related]
35. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
Wang Z; Petricca J; Liu M; Zhang S; Chen S; Li M; Besschetnova A; Patalano S; Venkataramani K; Siegfried KR; Macoska JA; Han D; Gao S; Vedadi M; Arrowsmith CH; He HH; Cai C
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2220472120. PubMed ID: 37549269
[TBL] [Abstract][Full Text] [Related]
36. E3 ubiquitin ligase neural precursor cell-expressed developmentally downregulated gene 4 motivates FOXA1 ubiquitination and restrains proliferation of diffuse large B-cell lymphoma cells via the Wnt/β-Catenin pathway.
Yang L; Li JN
Cell Biol Int; 2023 Oct; 47(10):1688-1701. PubMed ID: 37415495
[TBL] [Abstract][Full Text] [Related]
37. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
[TBL] [Abstract][Full Text] [Related]
38. The essential role of GATA transcription factors in adult murine prostate.
Xiao L; Feng Q; Zhang Z; Wang F; Lydon JP; Ittmann MM; Xin L; Mitsiades N; He B
Oncotarget; 2016 Jul; 7(30):47891-47903. PubMed ID: 27374105
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
40. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
